Trials / Active Not Recruiting
Active Not RecruitingNCT04871919
Prospective Observational Study of Filgotinib in Subjects With Rheumatoid Arthritis
A Prospective, Non-interventional Study of the Effectiveness, Safety, and Health Related Outcomes in Patients With Moderate to Severe Active Rheumatoid Arthritis Receiving Filgotinib
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,304 (actual)
- Sponsor
- Alfasigma S.p.A. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
An observational study to describe the effectiveness, safety, and patient-reported outcomes in patients with moderate to severe active rheumatoid arthritis (RA) receiving filgotinib in real-world setting.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Filgotinib | Tablets are administered in accordance with the product label |
Timeline
- Start date
- 2021-05-11
- Primary completion
- 2028-06-01
- Completion
- 2028-06-01
- First posted
- 2021-05-04
- Last updated
- 2025-09-15
Locations
89 sites across 6 countries: Belgium, Germany, Italy, Netherlands, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT04871919. Inclusion in this directory is not an endorsement.